Form 4: Celanese SVP Elliott Granted Equity Awards
Insider Transaction Report
Celanese Corporation's SVP, EM, Todd L. Elliott, was granted 12,579 restricted stock units and 17,558 nonqualified stock options on February 27, 2026.
Summary
- Todd L. Elliott, SVP, EM of Celanese Corporation, received equity awards on February 27, 2026.
- The awards include 12,579 time-based restricted stock units (RSUs), each representing the right to receive one share of Common Stock.
- These RSUs will vest in three installments: 33% on February 15, 2027, 33% on February 15, 2028, and 34% on February 15, 2029, contingent on continued employment.
- Additionally, Elliott was granted 17,558 time-based employee stock options with an exercise price of $49.09.
- The stock options will vest and become exercisable in three annual installments of 33%, 33%, and 34% beginning February 15, 2027, also subject to continued employment.
- The options have an expiration date of February 26, 2036.
- Following these transactions, Elliott beneficially owns 37,945 shares of Common Stock directly and 17,558 derivative securities (options) directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to align management interests with long-term shareholder value and ensure executive retention.
Positives
- Grant of 12,579 restricted stock units aligns executive compensation with shareholder interests.
- Grant of 17,558 nonqualified stock options provides a long-term incentive for performance.
- The vesting schedule for both RSUs and options promotes executive retention over several years.
Negatives
- The issuance of new equity awards could lead to minor share dilution, though typical for executive compensation plans.
Risks
- The vesting of RSUs and stock options is subject to continued employment, meaning the executive could forfeit unvested awards if employment ceases.
Future Outlook
The equity awards are structured with multi-year vesting schedules, indicating a long-term incentive and retention strategy for a key executive, with vesting periods extending through February 2029 for RSUs and options exercisable until February 2036.
Management Comments
- No direct quotes or paraphrased statements from company management were included in this Form 4 filing.
Industry Context
StockSavvy.ai notes that the grant of restricted stock units and stock options to a Senior Vice President is a standard practice in the chemicals industry and broader corporate landscape for executive compensation, aiming to align management incentives with long-term shareholder value creation and executive retention. This type of equity award is common across publicly traded companies like DuPont or Dow Inc. to incentivize key personnel.
Comparison to Industry Standards
- The use of time-based restricted stock units and nonqualified stock options is a common compensation structure for senior executives in large chemical companies, similar to practices observed at peers such as DuPont de Nemours, Inc. (DD) or LyondellBasell Industries N.V. (LYB).
- The multi-year vesting schedule (3 years for RSUs, 3 annual installments for options) is consistent with industry benchmarks designed to promote long-term retention and performance alignment, often seen in companies like BASF SE or Covestro AG.
- The exercise price of $49.09 for the options would typically be the closing price of Celanese Corp (CE) common stock on the grant date, a standard practice to ensure options are granted at fair market value.
Related Party Transactions
- Grant of 12,579 restricted stock units to SVP, EM Todd L. Elliott.
- Grant of 17,558 nonqualified stock options to SVP, EM Todd L. Elliott.
Stakeholder Impact
- Shareholders: Potential minor dilution from new equity awards, but also improved alignment of executive incentives with long-term shareholder value.
- Employees: Standard executive compensation practices may signal stability in leadership.
Next Steps
- Continued employment of Todd L. Elliott for vesting of RSUs and stock options.
- Vesting of 33% of RSUs and 33% of stock options on February 15, 2027.
- Vesting of 33% of RSUs on February 15, 2028.
- Vesting of 34% of RSUs on February 15, 2029.
- Exercise of stock options by February 26, 2036.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Date of earliest transaction (grant date for RSUs and stock options). |
| 03/03/2026 | Signature date of the filing by Christine Dryden, Attorney-in-Fact for Todd L. Elliott. |
| 02/15/2027 | First vesting date for 33% of RSUs and 33% of stock options. |
| 02/15/2028 | Second vesting date for 33% of RSUs. |
| 02/15/2029 | Third vesting date for 34% of RSUs. |
| 02/26/2036 | Expiration date for nonqualified stock options. |
Recommendation
holdThis Form 4 filing details a routine executive compensation grant, which is a standard practice for retaining and incentivizing senior management. It does not present new information that would fundamentally alter the investment thesis for Celanese Corp, thus a 'hold' recommendation is appropriate as it reflects business as usual.
Keywords
Celanese Corp, CE, Todd L. Elliott, SEC Form 4, Restricted Stock Units, Stock Options, Equity Grant, Executive Compensation, Insider Transaction, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.